Matches in Wikidata for { <http://www.wikidata.org/entity/Q92908800> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q92908800 description "article scientifique publié en 2019" @default.
- Q92908800 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q92908800 description "scientific article published on 08 June 2019" @default.
- Q92908800 description "wetenschappelijk artikel" @default.
- Q92908800 description "наукова стаття, опублікована 8 червня 2019" @default.
- Q92908800 name "Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility" @default.
- Q92908800 name "Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility" @default.
- Q92908800 type Item @default.
- Q92908800 label "Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility" @default.
- Q92908800 label "Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility" @default.
- Q92908800 prefLabel "Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility" @default.
- Q92908800 prefLabel "Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility" @default.
- Q92908800 P1433 Q92908800-EBB00F67-7E2F-470D-B706-E0CB9C58B53D @default.
- Q92908800 P1476 Q92908800-F722D34D-446D-4637-9246-907A7C8ABEF3 @default.
- Q92908800 P2093 Q92908800-55395948-1230-4C7A-8764-AD463A4ED5F4 @default.
- Q92908800 P2093 Q92908800-66C1851E-3E97-40BF-A939-54830A469C25 @default.
- Q92908800 P2093 Q92908800-9A8A99EF-D93F-423F-80B3-4476E6CF702D @default.
- Q92908800 P2093 Q92908800-B545E0EE-3076-4B7A-B0B3-33BF76DB173B @default.
- Q92908800 P2093 Q92908800-C7FDCAEE-EC9B-4CED-8400-4298EC366745 @default.
- Q92908800 P2093 Q92908800-DAE55632-53D1-4812-B2B7-5D34F213996B @default.
- Q92908800 P304 Q92908800-6B141930-49ED-4366-8E0C-F12B0E724710 @default.
- Q92908800 P31 Q92908800-4FBD4A19-FDAD-4452-A4D8-D3AEAF26F326 @default.
- Q92908800 P356 Q92908800-28E7941F-3624-4C5F-8C80-CD791C6EB631 @default.
- Q92908800 P478 Q92908800-46B048B8-5385-4F1E-8F32-3DF6A4A6D5FA @default.
- Q92908800 P50 Q92908800-00DA0304-5E13-4F3E-A707-FB6282D2C093 @default.
- Q92908800 P50 Q92908800-AB7F60B6-9D51-49C9-91E1-EC325DD86C9D @default.
- Q92908800 P577 Q92908800-C5E773C2-5163-4D74-AAC1-F133A3DB4A8B @default.
- Q92908800 P698 Q92908800-7EE66304-50AF-48AA-AA89-2516F1F72716 @default.
- Q92908800 P921 Q92908800-3903B442-8699-4586-92E5-496E53A31AFE @default.
- Q92908800 P356 J.RMED.2019.06.004 @default.
- Q92908800 P698 31220806 @default.
- Q92908800 P1433 Q2659932 @default.
- Q92908800 P1476 "Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility" @default.
- Q92908800 P2093 "Daniel J Bratton" @default.
- Q92908800 P2093 "Frank C Albers" @default.
- Q92908800 P2093 "Mark C Liu" @default.
- Q92908800 P2093 "Namhee Kwon" @default.
- Q92908800 P2093 "Soichiro Hozawa" @default.
- Q92908800 P2093 "Steven W Yancey" @default.
- Q92908800 P304 "69-75" @default.
- Q92908800 P31 Q13442814 @default.
- Q92908800 P356 "10.1016/J.RMED.2019.06.004" @default.
- Q92908800 P478 "154" @default.
- Q92908800 P50 Q33113039 @default.
- Q92908800 P50 Q61145656 @default.
- Q92908800 P577 "2019-06-08T00:00:00Z" @default.
- Q92908800 P698 "31220806" @default.
- Q92908800 P921 Q35869 @default.